FDA encourages discovery and development of new tools to fight antimicrobial-resistant infections

Antimicrobial drug resistant infections is a critical public health concern and a growing threat to patients. Trana Discovery discovers new treatments for infections with human and agricultural applications.

Bacteria cells

Each year there are at least 2 million people become infected with bacteria that are resistant to antibiotics and 23,000 people die each year as a direct result of these infections.

As more and more bacteria grow resistant to currently available antibiotics, we must tackle the issue on all fronts and seek new approaches to this persistent and potentially deadly problem. This means helping to ensure good antibiotic stewardship and use in appropriate clinical scenarios. It also means spurring the development of new antibiotics, for instance, by pursuing novel incentive models for developers that take into consideration the challenging economic and usage dynamics of these products.